MedPath

Vitrification for Ovarian Tissue Harvesting

Not Applicable
Conditions
Ovary; Anomaly
Registration Number
NCT03649087
Lead Sponsor
Maximilian Franz, M.D.
Brief Summary

Increasing interest has emerged concerning ovarian tissue cryopreservation and subsequent transplantation as a potential way of preserving fertility in cancer patients as well as for women who just wish to delay childbearing. As the majority of existing protocols use the slow freezing method, this study aims to test vitrification techniques of ovarian cortex.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • female-to-male transsexuals
  • gender completing operation
  • signed informed consent form
  • willingness to donate ovarian tissue for research purposes
  • age >=18 years
Exclusion Criteria
  • malignant disease
  • age under 18 years
  • refusal to donate ovarian tissue

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
survival of ovarian tissue2 days until 2 years after freezing

histologic and enzymatic evaluation of ovarian tissue with respect to survival and functionality of ovarian follicles

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Clinic of Obstetrics and Gynaecology of the Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath